WS #10987
Zymeworks acquires Theravance Biopharma for $929M; Martin Marietta strikes $13.5B deal for limestone supplier; Matador Resources' JV buys Cardinal Midstream for $752M.
M&A Activity
Zymeworks acquires Theravance Biopharma for $929M; Martin Marietta strikes $13.5B deal for limestone supplier; Matador Resources' JV buys Cardinal Midstream for $752M.